Consulting
Our strengths: Expert insights, tailored to your organization’s needs
Support to the industry
The radionuclide and radiopharmaceutical industry comprise hundreds of players: from small laboratories developing innovative therapies or production methods to industrial-scale manufacturers racing against time to supply hospitals with radiopharmaceuticals worldwide. Over the years, the MEDraysintell team has built strong, trusted relationships across the sector, supporting projects from feasibility studies to safe and effective commercial operations throughout the entire radionuclide and radiopharmaceutical supply chain. Our competencies covers entire supply chains: source material supply, enrichment, irradiation, processing, radiopharmaceutical manufacturing, transport and use in medical environment.
Our support services to the radionuclide and radiopharmaceutical industry include:
- Market intelligence and strategic planning, through market studies, business case development, and optioneering studies tailored to your objectives.
- Industrial strategy and investment optimization, through high-level advisory for shaping corporate strategies, design and scaling-up of manufacturing capabilities.
- Owner’s engineer services, for new irradiation installations (research reactors, accelerators, etc.), from early design to commissioning and operational support.
Support to investors
In recent years, the nuclear medicine market has experienced rapid growth, driven by the promising future of therapeutic radiopharmaceuticals, and marked by major acquisitions from leading pharmaceutical companies. In 2024, main deals were Bristol-Myers Squibb acquisition of RayzeBio for 4,1bn$, AstraZeneca acquisition of Fusion Pharmaceuticals for 2.4bn$ and Novartis acquisition of Mariana Oncology for 1,75bn$.
MEDraysintell team regularly supports investment funds, private investors, and global consulting firms in conducting due diligence on stakeholders across the radiopharmaceutical and radionuclide supply chains.
Leveraging deep technical knowledge of the nuclear medicine ecosystem, combined with proven expertise in large-scale project financing and M&A in the nuclear sector, our team delivers tailored technical and investment advisory services, including:
- Strategic assessments (stakeholder mapping, competitive landscape analysis, strategic positioning review, capability assessment, risk evaluation, etc.),
- Market research, business model definition, and optioneering studies,
- M&A advisory, including technical and financial due diligence
- Independent audits and project reviews,
- Investment planning and project structuring
- Expert call to engage directly with our team
Support to public institutions
MEDraysintell/NucAdvisor has been a major contributor to European Commission DG ENER & JRC latest initiatives for the applications of ionising radiation in healthcare, from quality and safety considerations to securing the supply of medical radioisotopes in Europe.
Our expert knowledge, combined with robust experience in collaborating with European medical and industrial professional organizations, enables us to serve public interests.
Support to public institutions services include:
- Radionuclide and radiopharmaceutical supply chain mapping, current demand and projections, optioneering studies,
- Compliance assessments and support to application of European or national regulations on ionising medical applications (e.g., Directive 2013/59),
- Organisation and technical coordination of scientific conferences and events
Support to public institutions
MEDraysintell/NucAdvisor has been a major contributor to European Commission DG ENER & JRC latest initiatives for the applications of ionising radiation in healthcare, from quality and safety considerations to securing the supply of medical radioisotopes in Europe.
Our expert knowledge, combined with robust experience in collaborating with European medical and industrial professional organizations, enables us to serve public interests.
Support to public institutions services include:
- Radionuclide and radiopharmaceutical supply chain mapping, current demand and projections, optioneering studies,
- Compliance assessments and support to application of European or national regulations on ionising medical applications (e.g., Directive 2013/59),
- Organisation and technical coordination of scientific conferences and events
Our references
Overview of completed projects
by MEDraysintell team
FAQ
About our consulting services
What is your process for engaging with a new client?
Our engagement process begins with a complimentary introductory call designed to gain a clear understanding of your specific needs, challenges, and objectives. During this conversation, we listen carefully to your priorities and gather relevant information to assess how our expertise can best support your project. Following this initial dialogue, we provide a tailored proposal outlining the scope of work, deliverables, timelines, and pricing. If we determine that your requirements fall outside our core areas of expertise, we commit to connecting you with trusted partners in our extensive professional network to ensure you receive the most appropriate support. Throughout the collaboration, we maintain open communication to adapt our approach as needed and ensure your objectives are met efficiently and effectively
How do you ensure the confidentiality of the projects you manage?
At MEDraysIntell, our expert team brings deep knowledge to both consulting and report publishing, enabling a seamless flow of insights while upholding the highest standards of confidentiality. We apply strict internal protocols to ensure that all sensitive client information accessed during consulting assignments is securely protected and never integrated into our public reports. This clear and disciplined separation allows us to deliver tailored, high-value consulting services alongside comprehensive, independent market intelligence, strengthening client trust and reinforcing our commitment to professionalism and discretion.
What sets us apart from standard consulting firms?
MEDraysIntell stands out by focusing exclusively on the nuclear medicine sector, allowing us to develop unparalleled expertise and deep industry knowledge. Unlike generalist consultancy companies, our team combines decades of hands-on experience with proprietary research and data analytics to deliver precise, actionable insights. Our strong industry relationships provide privileged access to key stakeholders, enabling us to offer strategic advice grounded in real-world context. This specialized focus ensures our clients receive tailored, high-impact guidance that generic firms cannot match.